Skip to content

Drug interactions

Dronedarone + Infigratinib

Severity: Major

Dronedarone and Infigratinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dronedarone, a moderate CYP3A4 inhibitor, may increase infigratinib exposure and its adverse effects such as hyperphosphatemia, ocular toxicity and fatigue. Infigratinib is a CYP3A4 substrate, so higher levels are plausible.

What this interaction means in plain words

Dronedarone and Infigratinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Dronedarone inhibits CYP3A4, reducing the metabolic clearance of infigratinib.

What to do

Prefer an alternative antiarrhythmic. If unavoidable, monitor closely for infigratinib toxicity and consider dose reduction per product labeling.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dronedarone and Infigratinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dronedarone with Infigratinib?

MediHelp rates the interaction as major. Dronedarone and Infigratinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dronedarone, a moderate CYP3A4 inhibitor, may increase infigratinib exposure and its adverse effects such as hyperphosphatemia, ocular toxicity and fatigue. Infigratinib is a CYP3A4 substrate, so higher levels are plausible.

How serious is the interaction between Dronedarone and Infigratinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an alternative antiarrhythmic. If unavoidable, monitor closely for infigratinib toxicity and consider dose reduction per product labeling.

What other medicines interact with Dronedarone?

MediHelp also lists interactions of Dronedarone with, for example, Adagrasib, Amiodarone, Arsenic trioxide. The full list is on the Dronedarone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in